NHL alumni teaming up with pot company on concussion research

The NHL Alumni Association is partnering with Canopy Growth to examine whether cannabis could be used to treat post-concussion diseases.

The NHLAA and the Smiths Falls, Ont.-based marijuana producer announced this weekend they plan to conduct a study to determine if cannabinoids (CBD) could help with concussion-related ailments.

Researchers estimate that there could be up to 3.8 million athletes suffering from a sports-related concussion each year and that at least one in 10 of these athletes will develop post-concussion diseases.

“NHL alumni gave everything they had during their careers, but the physical consequences after they hang up their skates can be devastating for both players and their loved ones for the rest of their lives,” said Glenn Healy, the executive director of the NHLAA.

“This study offers alumni the promise of help and hope, and we are excited to participate in what could become a true game-changer in allowing these professional athletes to finish strong.”

Roughly 100 former NHL players will participate in the study, which will launch this summer and last a year to complete.